Foraprl 400 Dpicaps is a combination medication containing Formoterol (6mcg) and Budesonide (400mcg), designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol is a long-acting beta2-adrenergic agonist that helps relax the muscles in the airways, improving airflow and making breathing easier. Budesonide is an inhaled corticosteroid that reduces inflammation and swelling in the airways, thereby preventing asthma attacks and exacerbations of COPD. The dual action of Formoterol and Budesonide provides both immediate bronchodilation and long-term control of airway inflammation, enhancing lung function and reducing symptoms such as wheezing, coughing, and shortness of breath. Foraprl 400 Dpicaps is typically prescribed for patients requiring regular maintenance therapy to control persistent respiratory symptoms and improve quality of life. It is important to use this medication exactly as directed by a healthcare professional, as improper use may lead to side effects or reduced efficacy. Common side effects may include throat irritation, hoarseness, or oral thrush, which can be minimized by rinsing the mouth after inhalation. This medication is not intended for relief of acute bronchospasm and should be used consistently for optimal results.